Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3422 of 6351
-
Your gut bugs could predict your stroke risk
Knowledge-focused OngoingThe main aim of this project is to demonstrate an association between gut and oral microbiota and their metabolites to carotid atherosclerosis and risk of ischemic stroke. The investigators aim to show that these metabolite levels are diet-dependent (mainly egg yalk and red meat…
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Heart rate training boosts exercise benefits for cancer survivors
Symptom relief CompletedAPACCHE (Adapted Physical Activity and Cardiac Coherence in HEmatologic patients) study investigates effects of heart rate variability biofeedback training, combined with classical adapted physical activity, on health-related quality of life in patients previously treated for hem…
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Can zoom help teens lose weight? new study tests virtual group visits
Disease control CompletedSummary Description The goal of this intervention study is to test how well does a weight management curriculum work in virtual group-based medical visits (telehealth) for the treatment of adolescents with obesity. The main questions it aims to answer are: * How well does provi…
Sponsor: Children's Hospital Los Angeles • Aim: Disease control
Last updated Jun 26, 2026 14:43 UTC
-
Talking your way to better sleep: therapy eases insomnia in chronically ill
Symptom relief CompletedInsomnia is common with co-morbid somatic disease, e.g. rheumatic disease, cancer, heart and lung disease or gastrointestinal disorders. Pain, breathing difficulties and other symptoms of disease can worsen sleep problems and cause insomnia. In turn, insomnia may aggravate pain, …
Sponsor: Diakonhjemmet Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New hope for rare eye parasite: study compares drug cocktails and steroid timing
Disease control CompletedThis is a study of optimal treatments for acanthamoeba keratitis. In the first part of the study, participants will be randomized to chlorhexidine monotherapy or chlorhexidine plus povidone iodine. After four weeks of therapy, participants will be re-randomized to early corticost…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can online group therapy help curb cybersex addiction?
Symptom relief CompletedThe goal of this clinical trial is to study the effectiveness of an online group therapy to treat people with cybersex addiction or online sexual compulsivity. It will compare group therapy to individual therapy. It uses cognitive behavioral therapy, a therapy that aims to change…
Sponsor: Universitat Jaume I • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Scientists probe acid 'Pain Channels' in arthritic joints
Knowledge-focused CompletedIn recent years, ion channels have emerged as new therapeutic targets for pain. Among these channels, ASICs (Acid Sensing Ion Channels) are of particular interest because they are directly activated by extracellular acidity, which is a major cause of pain. Indeed, many painful co…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Inflammation may predict success of targeted cancer therapy
Knowledge-focused CompletedCancer-derived inflammation attenuates the efficacy of adjuvant chemotherapy (CT) in postoperative or metastatic colorectal cancer (mCRC). However, its role in mCRC patients receiving first-line Bevacizumab combined with chemotherapy (Bev/CT) remains unknown. In this prospective …
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Can MRI scans reveal how ANO5 muscle disease progresses?
Knowledge-focused OngoingThe aim of the study is to investigate progression in muscle affection in patients with pathogenic variants in the anoctamin 5 gene to: 1. investigate possible progression of disease over time 2. investigate good and reliable outcome measures
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Zap to grab: can mild electricity help kids with stroke reach and play?
Symptom relief CompletedEvery year about 1 out of every 1,600-5,000 infants has a stroke around the time of birth. Many of these children will have lifelong physical problems. For example, the arm muscles are often paralyzed. This makes every day activities, like reaching and grasping objects, very diff…
Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
NIH launches major study to uncover teen Depression's secrets
Knowledge-focused Recruiting nowThis research study seeks to find causes and treatments of depression in teenagers. The study goals are to increase our knowledge of treatments for depression and understand how the brain changes when teenagers have depression. The study will also compare teenagers with depressio…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
New MRI technique aims to solve brain tumor treatment mystery
Diagnosis Stopped earlyThis pilot phase II trial studies how well ferumoxytol magnetic resonance imaging (MRI) works in assessing response to pembrolizumab in patients with glioblastoma. Diagnostic procedures, such as ferumoxytol MRI, may help measure a patient's response to pembrolizumab treatment.
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Jun 26, 2026 15:10 UTC
-
New drug combo shows promise in small melanoma trial
Disease control CompletedThis pilot early phase I trial studies the side effects and how well imiquimod and pembrolizumab work in treating patients with stage IIIB-IV melanoma. Imiquimod may stimulate the immune system. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's …
Early phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a PET scan predict who will suffer chronic leg pain after a DVT?
Knowledge-focused CompletedThe goal of this study is to develop strategies that will improve outcomes for patients with deep vein thrombosis (DVT), using in vivo FDG-PET inflammation imaging to better predict the development of the post-thrombotic syndrome (PTS). New approaches are needed to improve the ou…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New combo treatment targets returned prostate cancer
Disease control Stopped earlyThe purpose of this study is to evaluate the safety and effectiveness of combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) to the pelvis and 6 months of hormonal therapy, otherwise known as short term androgen deprivation therapy (STAD), as treat…
Phase 1/2 • Sponsor: Loyola University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Scientists hunt for genetic clues in Virus-Linked cancers
Knowledge-focused Recruiting nowBackground: A person s genome is the collection of all their genes. A gene instructs individual cells to make proteins. Proteins are involved in all of our body s chemical processes. Genome sequencing allows researchers to find variations in genes. Some of these are normal and a…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Folic acid may soothe cancer treatment side effects
Symptom relief Recruiting nowFASTERCC: Folic acid supplement versus placebo for treating mucositis adverse events in metastatic renal cell carcinoma patients receiving targeted therapy. A randomized, double-blind trial from the Danish renal cancer group (DARENCA study-4)
Phase 2 • Sponsor: Niels Fristrup • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Learning to beat cancer pain: new program shows promise
Symptom relief CompletedPain is one of the most feared and burdensome symptoms experienced by cancer patients. Its prevalence has been estimated by INCa1 in 2012 at 48% in patients undergoing cancer treatment, and unrelieved pain is directly associated with significantly reduced quality of life (QoL)2. …
Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New hope for cedar fever sufferers: drug eases severe allergy symptoms
Symptom relief CompletedThe purpose of this study was to demonstrate the efficacy and safety of omalizumab compared with placebo, on top of SoC (anti-histamine and nasal corticosteroid) in adult and adolescent patients with severe Japanese cedar pollinosis, whose symptoms were inadequately controlled de…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Blood test may predict prostate cancer treatment success
Knowledge-focused Recruiting nowParticipants to the study will be assigned to 7 cohorts according to the stage of disease and planned antitumor treatment at time of study entry. In all patients, 12 ml of blood sample will be collected in EDTA tube for analysis of biological biomarkers in different time points.
Sponsor: Oncology Institute of Southern Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC